Why pesticides could be a common cause of prostate and breast cancers in the French Caribbean Island, Martinique. An overview on key mechanisms of pesticide-induced cancer

Biomedicine and Pharmacotherapy

Volumn 63, Issue 6, 2009, Pages 383-395

  Landau Ossondo, M ^a,b   Rabia, N ^a   Jos Pelage, J ^b   Marquet, L M ^b,c   Isidore, Y ^a,b   Saint Aime C ^b,d   Martin, M ^e   Irigaray, P ^e   Belpomme, D ^d,e  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^b Joint Committee of Medical Doctors for Martinique's Environmental Health ^*

^c Department of Paediatrics   (Martinique)

^d Association for Research and Treatments Against Cancer ARTAC   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Breast cancer; Cancer; Carcinogenesis; Endocrine disruptors; Foetus susceptibility; Low dose; Obesity; Pesticides; Prostate cancer

Indexed keywords

ALDRIN; CAMPHECLOR; CHLORDANE; CHLORDECONE; CHLORPHENOTANE; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; DIELDRIN; ENDOCRINE DISRUPTOR; ENDOSULFAN; ENDRIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; HEXACHLOROBENZENE; LINDANE; MIREX; ORGANOCHLORINE PESTICIDE; PESTICIDE; SIMAZINE; TESTOSTERONE;

BREAST CANCER; CANCER INCIDENCE; CARCINOGENESIS; CARIBBEAN ISLANDS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; FRANCE; GENERAL PRACTITIONER; GENETIC SUSCEPTIBILITY; GROWTH CURVE; HUMAN; MARTINIQUE; MEDICAL SPECIALIST; PEDIATRICIAN; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH SERVICE; REVIEW;

BREAST NEOPLASMS; CARCINOGENS; CHILD; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; HYDROCARBONS, CHLORINATED; MALE; MARTINIQUE; PESTICIDES; PREGNANCY; PRIMARY PREVENTION; PROSTATIC NEOPLASMS;

EID: 68949150796     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.04.043     Document Type: Review

References (141)

1. Belpomme D., Irigaray P., Ossondo M., Vacque D., and Martin M. Prostate cancer as an environmental disease: an ecological study in the French Caribbean islands, Martinique and Guadeloupe. Int J Oncol 34 (2009) 1037-1044
2. Remontet L., Buemi A., Velten M., Jougla E., and Esteve J. Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000 (2003), InVS
3. Bocquene G., and Franco A. Pesticide contamination of the coastline of Martinique. Mar Pollut Bull 51 (2005) 612-619
4. IFEN (Institut Français de l'Environnement). Les pesticides dans les eaux. Données 2005 (2007), IFEN (Institut Français de l'Environnement) no 9.
5. Cabidoche Y.M., Achard R., Cattan P., Clermont-Dauphin C., Massat F., and Sansoulet J. Long-term pollution by chlordecone of tropical volcanic soils in the French West Indies: a simple leaching model accounts for current residue. Environ Pollut (2009) doi:10.1016/j.envpol.2008.12.015
6. Martin M. Les pesticides Organochlorés. Recherches des résidus dans le tissu adipeux humain et animal en Martinique. Medical thesis. INRA Antilles-Guyane; 1973.
7. Morrison H., Savitz D., Semenciw R., Hulka B., Mao Y., Morison D., et al. Farming and prostate cancer mortality. Am J Epidemiol 137 (1993) 270-280
8. Ritchie J.M., Vial S.L., Fuortes L.J., Guo H., Reedy V.E., and Smith E.M. Organochlorines and risk of prostate cancer. J Occup Environ Med 45 (2003) 692-702
9. Alavanja M.C., Samanic C., Dosemeci M., Lubin J., Tarone R., Lynch C.F., et al. Use of agricultural pesticides and prostate cancer risk in the agricultural health study cohort. Am J Epidemiol 157 (2003) 800-814
10. Van Maele-Fabry G., and Willems J.L. Prostate cancer among pesticide applicators: a meta-analysis. Int Arch Occup Environ Health 77 (2004) 559-570
11. Van Maele-Fabry G., Libotte V., Willems J., and Lison D. Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers. Cancer Causes Control 17 (2006) 353-373
12. Bassil K.L., Vakil C., Sanborn M., Cole D.C., Kaur J.S., and Kerr K.J. Cancer health effects of pesticides: systematic review. Can Fam Physician 53 (2007) 1704-1711
13. Meyer T.E., Coker A.L., Sanderson M., and Symanski E. A case-control study of farming and prostate cancer in African-American and Caucasian men. J Occup Environ Med 64 (2007) 155-160
14. Prins G.S. Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer 15 (2008) 649-656
15. Agricultural Health Study. Available at: www.aghealth.org.
16. Mahajan R., Bonner M.R., Hoppin J.A., and Alavanja M.C. Phorate exposure and incidence of cancer in the agricultural health study. Environ Health Perspect 114 (2006) 1205-1209
17. Usmani K.A., Cho T.M., Rose R.L., and Hodgson E. Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals. Drug Metab Dispos 34 (2006) 1606-1614
18. Settimi L., Masina A., Andrion A., and Axelson O. Prostate cancer and exposure to pesticides in agricultural settings. Int J Cancer 104 (2003) 458-461
19. Mills P.K., and Yang R. Prostate cancer risk in California farm workers. J Occup Environ Med 45 (2003) 249-258
20. Hardell L., Andersson S.O., Carlberg M., Bohr L., van Bavel B., Lindström G., et al. Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer. J Occup Environ Med 48 (2006) 700-707
21. Krieger N., Wolff M.S., Hiatt R.A., Rivera M., Vogelman J., and Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86 (1994) 589-599
22. Stellman S.D., Djordjevic M.V., Britton J.A., Muscat J.E., Citron M.L., Kemeny M., et al. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev 9 (2000) 1241-1249
23. Safe S.H. Xenoestrogens and breast cancer. N Engl J Med 337 (1997) 1303-1304
24. Snedeker S. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect 109 (2001) 35-47
25. Krstevska-Konstantinova M., Charlier C., Craen M., Du Caju M., Heinrichs C., de Beaufort C., et al. Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. Hum Reprod 16 (2001) 1020-1026
26. Cohn B.A., Wolff M.S., Cirillo P.M., and Sholtz R.I. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect 115 (2007) 1406-1414
27. Rudel R.A., Attfield K.R., Schifano J.N., and Brody J.G. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 109 (2007) 2635-2666
28. Mills P.K., and Yang R. Regression analysis of pesticide use and breast cancer incidence in California Latinas. J Environ Health 68 (2006) 15-22
29. Hopenhayn-Rich C., Stump M.L., and Browning S.R. Regional assessment of atrazine exposure and incidence of breast and ovarian cancers in Kentucky. Arch Environ Contam Toxicol 42 (2002) 127-136
30. Abdalla M.H., Gutierrez-Mohamed M.L., and Farah I.O. Association of pesticide exposure and risk of breast cancer mortality in Mississippi. Biomed Sci Instrum 39 (2003) 397-401
31. Band P.R., Le N.D., Fang R., Deschamps M., Gallagher R.P., and Yang P. Identification of occupational cancer risks in British Columbia. A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med 42 (2000) 284-310
32. Dolapsakis G., Vlachonikolis I.G., Varveris C., and Tsatsakis A.M. Mammographic findings and occupational exposure to pesticides currently in use on Crete. Eur J Cancer 37 (2001) 1531-1536
33. Duell E.J., Millikan R.C., Savitz D.A., Newman B., Smith J.C., Schell M.J., et al. A population-based case-control study of farming and breast cancer in North Carolina. Epidemiology 11 (2000) 523-531
34. Wassermann M., Nogueira D.P., Tomatis L., Mirra A.P., Shibata H., Arie G., et al. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15 (1976) 478-484
35. Unger M., and Olsen J. Organochlorine compounds in the adipose tissue of deceased people with and without cancer. Environ Res 23 (1980) 257-263
36. Unger M., Kiaer H., Blichert-Toft M., Olsen J., and Clausen J. Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res 4 (1984) 24-28
37. Charlier C., Albert A., Herman P., Hamoir E., Gaspard U., Meurisse M., et al. Breast cancer and serum organochlorine residues. Occup Environ Med 60 (2003) 348-351
38. Demers A., Ayotte P., Brisson J., Dodin S., Robert J., and Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev 9 (2000) 161-166
39. Romieu I., Hernandez-Avila M., Lazcano-Ponce E., Weber J.P., and Dewailly E. Breast cancer, lactation history, and serum organochlorines. Am J Epidemiol 152 (2000) 363-370
40. Wolff M.S., Toniolo P.G., Lee E.W., Rivera M., and Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85 (1993) 648-652
41. Dewailly E., Dodin S., Verreault R., Ayotte P., Sauvé L., Morin J., et al. High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86 (1994) 232-234
42. Dorgan J.F., Brock J.W., Rothman N., Needham L.L., Miller R., Stephenson Jr. H.E., et al. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 10 (1999) 1-11
43. Ibarluzea Jm J., Fernández M.F., Santa-Marina L., Olea-Serrano M.F., Rivas A.M., Aurrekoetxea J.J., et al. Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control 15 (2004) 591-600
44. Mussalo-Rauhamaa H., Hasanen E., Pyysalo H., Antervo K., Kauppila R., and Pantzar P. Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer 66 (1990) 2124-2128
45. Cassidy R.A., Natarajan S., and Vaughan G.M. The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat 90 (2005) 55-64
46. Hoyer A.P., Grandjean P., Jorgensen T., Brock J.W., and Hartvig H.B. Organochlorine exposure and risk of breast cancer. Lancet 352 (1998) 1816-1820
47. Hoyer A.P., Jorgensen T., Brock J.W., and Grandjean P. Organochlorine exposure and breast cancer survival. J Clin Epidemiol 53 (2000) 323-330
48. Falck Jr. F., Ricci Jr. A., Wolff M.S., Godbold J., and Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47 (1992) 143-146
49. Woolcott C.G., Aronson K.J., Hanna W.M., SenGupta S.K., McCready D.R., Sterns E.E., et al. Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12 (2001) 395-404
50. Snedeker S.M. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect 109 (2001) 35-47
51. Muñoz-de-Toro M., Durando M., Beldoménico P.M., Beldoménico H.R., Kass L., García S.R., et al. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas. Breast Cancer Res 8 (2006) R47
52. Fenichel P., and Brucker-Davis F. Environmental endocrine disruptors and breast cancer: new risk factors?. Gynecol Obstet Fertil 36 (2008) 969-977
53. Brody J.G., and Rudel R.A. Environmental pollutants and breast cancer. Environ Health Perspect 111 (2003) 1007-1019
54. Davis D.L., Bradlow H.L., Wolff M., Woodruff T., Hoel D.G., and Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101 (1993) 372-377
55. Soto A.M., Chung K.L., and Sonnenschein C. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 102 (1994) 380-383
56. Grönberg H. Prostate cancer epidemiology. The Lancet 361 (2003) 859-864
57. Nelson W.G., De Marzo A.M., and Isaacs W.B. Prostate cancer. N Engl J Med 349 (2003) 366-381
58. McPherson K., Steel C.M., and Dixon J.M. ABC of breast diseases. Breast cancer - epidemiology, risk factors and genetics. BMJ 321 (2000) 624-628
59. Madigan M.P., Ziegler R.G., Benichou J., Byrne C., and Hoover R.N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87 (1995) 1681-1685
60. Belpomme D. Cancer and the environment: facts, figures, methods and misinterpretations. Biomed Pharmacother 61 (2007) 611-613
61. Belpomme D., Irigaray P., Hardell L., Clapp R., Montagnier L., Epstein S., et al. The multitude and diversity of environmental carcinogens. Environ Res 105 (2007) 414-429
62. Safe S., and Papineni S. The role of xenoestrogenic compounds in the development of breast cancer. Trends Pharmacol Sci 27 (2006) 447-454
63. Modugno F., Weissfeld J.L., Trump D.L., Zmuda J.M., Shea P., Cauley J.A., et al. Allelic variants of aromatase and androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res 7 (2001) 3092-3096
64. Bouchardy C., Fioretta G., Verkooijen H.M., Vlastos G., Schaefer P., Delaloye J.F., et al. Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer 96 (2007) 1743-1746
65. Lemaire G., Mnif W., Mauvais P., Balaguer P., and Rahmani R. Activation of alpha- and beta-estrogen receptors by persistent pesticides in reporter cell lines. Life Sci 79 (2006) 1160-1169
66. Katzenellenbogen J.A., O'Malley B.W., and Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology-interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10 (1996) 119-131
67. Hall J.M., Couse J.F., and Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276 (2001) 36869-36872
68. Foster W.G., Younglai E.V., Boutross-Tadross O., Hughes C.L., and Wade M.G. Mammary gland morphology in sprague-dawley rats following treatment with an organochlorine mixture in utero and neonatal genistein. Toxicol Sci 77 (2004) 91-100
69. Escriva H., Bertrand S., and Laudet V. The evolution of the nuclear receptor superfamily. Essays Biochem 40 (2004) 11-26
70. Sonnenschein C., and Soto A.M. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 65 (1998) 143-150
71. Robison A.K., Sirbasku D.A., and Stancel G.M. DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett 27 (1985) 109-113
72. Robison A.K., Schmidt W.A., and Stancel G.M. Estrogenic activity of DDT: estrogen-receptor profiles and the responses of individual uterine cell types following o, p′-DDT administration. J Toxicol Environ Health 16 (1985) 493-508
73. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., and Serrano F.M. The E-SCREEN assay as a tool to identify estrogens. An update on estrogenic environmental pollutants. Environ Health Perspect 7 (1995) 113-122
74. Shekhar P.V., Werdell J., and Basrur V.S. Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines. J Natl Cancer Inst 89 (1997) 1774-1782
75. Bigsby R.M., Caperell-Grant A., and Madhukar B.V. Xenobiotics released from fat during fasting produce estrogenic effects in ovariectomised mice. Cancer Research 57 (1997) 865-869
76. Loeber J.G., and van Velsen F.L. Uterotrophic effect of β-HCH, a food chain contaminant. Food Addit Contam 1 (1984) 63-66
77. Willett K.L., Ulrich E.M., and Hites R.A. Differential toxicity and environmental fates of hexachlorocyclohexane isomers. Environ Sci Technol 32 (1998) 2197-2207
78. El-Mubarak A., and Huisingh D. Environmental estrogens: short-term exposure of low doses of lindane, dieldrin, dibutyl phthalate, and diethylhexyl phthalate increases uterine weight in young female mice. Anal Sci 17 (2001) i261-i264
79. Okubo T., Yokoyama Y., Kano K., Soya Y., and Kano I. Estimation of estrogenic and antiestrogenic activities of selected pesticides by MCF-7 cell proliferation assay. Arch Environ Contam Toxicol 46 (2004) 445-453
80. Li J., Li N., Ma M., Giesy J.P., and Wang Z. In vitro profiling of the endocrine disrupting potency of organochlorine pesticides. Toxicol Lett 183 (2008) 65-71
81. Gellert R.J. Kepone, mirex, dieldrin, and aldrin: estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following neonatal treatment. Environ Res 16 (1978) 131-138
82. Hammond B., Katzenellenbogen B.S., Krauthammer N., and McConnell J. Estrogenic activity of the insecticide chlordecone (Kepone) and interaction with uterine estrogen receptors. Proc Natl Acad Sci U S A 76 (1979) 6641-6645
83. Johnson D.C. Estradiol-chlordecone (Kepone) interactions: additive effect of combinations for uterotropic and embryo implantation functions. Toxicol Lett 89 (1996) 57-64
84. Kelce W.R., Stone C.R., Laws S.C., Gray L.E., Kemppainen J.A., and Wilson E.M. Persistent DDT metabolite p, p′-DDE is a potent androgen receptor antagonist. Nature 375 (1995) 581-585
85. Danzo B.J. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ Health Perspect 105 (1997) 294-301
86. Gray L.E., Wolf C., Lambright C., Mann P., Price M., Cooper R.L., et al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p, p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 15 (1999) 94-118
87. Schrader T.J., and Cooke G.M. Examination of selected food additives and organochlorine food contaminants for androgenic activity in vitro. Toxicol Sci 53 (2000) 278-288
88. Andersen H.R., Vinggaard A.M., Rasmussen T.H., Gjermandsen I.M., and Bonefeld-Jørgensen E.C. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol 179 (2002) 1-12
89. Sanderson T., and van den Berg M. Interactions of xenobiotics with the steroid hormone biosynthesis pathway. Pure Appl Chem 75 (2003) 1957-1971
90. Chen S., Zhou D., Yang C., Okubo T., Kinoshita Y., Yu B., et al. Modulation of aromatase expression in human breast tissue. J Steroid Biochem Mol Biol 79 (2001) 35-40
91. You L., Sar M., Bartolucci E., Ploch S., and Whitt M. Induction of hepatic aromatase by p, p′-DDE in adult male rats. Mol Cell Endocrinol 178 (2001) 207-214
92. Laville N., Balaguer P., Brion F., Hinfray N., Casellas C., Porcher J.M., et al. Modulation of aromatase activity and mRNA by various selected pesticides in the human choriocarcinoma JEG-3 cell line. Toxicology 228 (2006) 98-108
93. Yang C., and Chen S. Two organochlorine pesticides, toxaphene and chlordane, are antagonists for ERRα-1 orphan receptor. Cancer Res 59 (1999) 4519-4524
94. Huggins C., and Hodges C.V. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 168 (2002) 9-12
95. Kuiper G.G.J.M., Carlquist M., and Gustafsson J.A. Estrogen is a male and female hormone. Sci Med 5 (1998) 36-45
96. Yang G.S., Wang Y., Wang P., and Chen Z.D. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer. Chin Med J (Engl) 120 (2007) 1611-1615
97. Noble R.L. Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol 23 (1982) 113-159
98. Bosland M.C. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monographs 27 (2000) 39-66
99. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19 (2000) 5406-5417
100. Lo S., King I., Allera A., and Klingmuller D. Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells. Toxicol In Vitro 21 (2007) 502-508
101. Bosland M.C. Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis. Ann N Y Acad Sci 1089 (2006) 168-176
102. Carruba G. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 102 (2007) 899-911
103. Friedman A.E. The estradiol-dihydrotestosterone model of prostate cancer. Theor Biol Med Model 2 (2005) 10
104. Kang K.S., Wilson M.R., Hayashi T., Chang C.C., and Trosko J.E. Inhibition of gap junctional intercellular communication in normal human breast epithelial cells after treatment with pesticides, PCBs, and PBBs, alone or in mixtures. Environ Health Perspect 104 (1996) 192-200
105. Klaunig J.E., Hartnett J.A., Ruch R.J., Weghorst C.M., Hampton J.A., and Schafer L.D. Gap junctional intercellular communication in hepatic carcinogenesis. Prog Clin Biol Res 340 (1990) 165-174
106. Klaunig J.E., and Ruch R.J. Biology of disease: role of inhibition of intercellular communication in carcinogenesis. Lab Invest 62 (1990) 135-146
107. Ruch R.J., and Klaunig J.E. Antioxidant prevention of tumor promoter induced inhibition of mouse hepatocyte intercellular communication. Cancer Lett 33 (1988) 137-150
108. IARC. IARC working group on the evolution of carcinogenic risks to humans: polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Monogr Eval Carcinog Risk Hum vol 69 (4-11 February 1997), IARC, Lyon, France
109. Selevan S.G., Kimmel C.A., and Mendola P. Identifying critical windows of exposure for children's health. Environ Health Perspect 108 (2000) 451-455
110. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A 94 (1997) 2056-2061
111. Welshons W.V., Nagel S.C., and vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 (2006) S56-S69
112. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., and vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 111 (2003) 994-1006
113. Prins G.S., Birch L., Yang W.Y., and Ho S.M. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 23 (2007) 374-382
114. Ho S.M., Tang W.Y., Belmonte de Frausto J., and Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66 (2006) 5624-5632
115. Prins G.S., Tang W.Y., Belmonte J., and Ho S.M. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clin Pharmacol Toxicol 102 (2008) 134-138
116. Prins G.S., Birch L., and Habermann H. Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev 13 (2001) 241-252
117. McLachlan J.A. Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22 (2001) 319-341
118. Moral R., Wang R., Russo I.H., Lamartiniere C.A., Pereira J., and Russo J. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol 196 (2008) 101-112
119. Wadia P.R., Vandenberg L.N., Schaeberle C.M., Rubin B.S., Sonnenschein C., and Soto A.M. Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect 115 (2007) 592-598
120. Durando M., Kass L., Piva J., Sonnenschein C., Soto A.M., Luque E.H., et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in wistar rats. Environ Health Perspect 115 (2007) 80-86
121. Soto A.M., Maffini M.V., and Sonnenschein C. Neoplasia as development gone awry: the role of endocrine disruptors. Int J Androl 31 (2008) 288-293
122. Soto A.M., Vandenberg L.N., Maffini M.V., and Sonnenschein C. Does breast cancer start in the womb?. Basic Clin Pharmacol Toxicol 102 (2008) 125-133
123. Gray L.J. Chemical-induced alterations of sexual differentiation: a review of effects in humans and rodents (1992), Scientific Publishing Princeton, Princeton p. 230-303
124. Markey C.M., Luque E.H., Munoz De Toro M., Sonnenschein C., and Soto A.M. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 65 (2001) 1215-1223
125. Vom Saal F.S., and Welshons W.V. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 100 (2006) 50-76
126. You L., Gazi E., Archibeque-Engle S., Casanova M., Conolly R.B., and Heck H.A. Transplacental and lactational transfer of p, p′-DDE in sprague-dawley rats. Toxicol Appl Pharmacol 157 (1999) 134-144
127. Huang J.S., Lee T.A., and Lu M.C. Prenatal programming of childhood overweight and obesity. Matern Child Health J 11 (2007) 461-473
128. Gladen B.C., Ragan N.B., and Rogan W.J. Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr 136 (2000) 490-496
129. Smink A., Ribas-Fito N., Garcia R., Torrent M., Mendez M.A., Grimalt J.O., et al. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr 97 (2008) 1465-1469
130. Dhom G. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol 106 3 (1983) 210-218
131. Vineis P., and Berwick M. The population dynamics of cancer: a Darwinian perspective. Int J Epidemiol 35 (2006) 1151-1159
132. Ames B.N., and Gold L.S. Environmental pollution, pesticides, and the prevention of cancer: misconceptions. FASEB J 11 (1997) 1041-1052
133. Irigaray P., Newby J.A., Lacomme S., and Belpomme D. Overweight/obesity and cancer genesis: more than a biological link. Biomed Pharmacother 61 (2007) 665-678
134. Lutz W.K. Dose-response relationship and low dose extrapolation in chemical carcinogenesis. Carcinogenesis 11 (1990) 1243-1247
135. Irigaray P., Lacomme S., Méjean L., and Belpomme D. Ex vivo study of incorporation into adipocytes and lipolysis-inhibition effect of polycyclic aromatic hydrocarbons. Toxicol Lett 187 (2009) 35-39
136. Irigaray P., Ogier V., Jacquenet S., Notet V., Sibille P., Méjean L., et al. Benzo[a]pyrene impairs beta-adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice. A novel molecular mechanism of toxicity for a common food pollutant. FEBS J 273 (2006) 1362-1372
137. Edwards T.M., and Myers J.P. Environmental exposures and gene regulation in disease etiology. Environ Health Perspect 115 (2007) 1264-1270
138. Armitage P. Multistage models of carcinogenesis. Environ Health Perspect 63 (1985) 195-201
139. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 293-300
140. Ferlay J., Bray F., Pisani D.M., and GLOBOCAN. Cancer incidence, mortality and prevalence worldwide. Available at: (2002), IARC Press, Lyon. http://www-dep.iarc.fr/ [accessed 1.04.08]
141. Score santé for French Caribbean and other department. Available at:. http://www.score-sante.org/score2008/tableau2008.html?idlibelle=o41-01-0 1-11-02